Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
Open accessAbstract
Pip is a lymphoid-restricted IRF transcription factor that is recruited to composite elements within immunoglobulin light-chain gene enhancers through a specific interaction with the Ets factor PU.1. We have examined the transcriptional regulatory properties of Pip as well as the requirements for its interaction with PU.1 and DNA to form a ternary complex. We demonstrate that Pip is a dichotomous regulator; it specifically stimulates transcription in conjunction with PU.1, but represses alpha/beta-interferon-inducible transcription in the absence of PU.1. Thus, during B-cell activation and differentiation, Pip may function both as an activator to promote B cell-specific gene expression and as a repressor to inhibit the antiproliferative effects of alpha/beta-interferons. Mutational analysis of Pip reveals a carboxy-terminal segment that is important for autoinhibition of DNA binding and ternary complex formation. A domain of Pip containing this segment confers autoinhibition and PU.1-dependent binding activity to the DNA-binding domain of the related IRF family member, p48. On the basis of these and other data we propose a model for PU.1/Pip ternary complex formation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A C-terminal regulatory domain in Pip is required for ternary complex assembly.
“A C-terminal regulatory domain within Pip itself is also required for ternary complex assembly (Brass et al., 1996).”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
The deletion analysis reports that Pip amino acids 410–439 are necessary for high-affinity ternary complex formation with PU.1. However, mutants lacking that segment still formed weak ternary complexes, so the paper does not show that the C-terminal domain is required for assembly altogether. The relevant passages are in the section on Pip repression of IFN-inducible transcription; page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPip deletion mutants 1-439 and 1-419 retained ternary complex formation with PU.1 and stimulated transcription comparably to full-length Pip.
“Pip deletion mutants which retained the ability to form a ternary complex with PU.1 (1-439 and 1-419; Brass et al., 1996; data not shown) stimulated transcription comparable with full-length Pip.”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
In the section on Pip amino acids 410–439 (page not supplied), Brass et al. report that deleting Pip to residue 439 did not affect ternary complex formation with PU.1. Our copy does not report the 1–419 mutant or show that these two mutants stimulated transcription comparably to full-length Pip; the citing sentence labels the transcription result “data not shown.” (LLM, conf=0.86)
Experimental — accuracy not yet measuredFull-length Pip cannot bind DNA without PU.1, whereas the C-terminal deletion mutant Pip 1-410 can bind DNA independently.
“As shown previously, full-length Pip cannot bind to DNA in the absence of PU.1; however, a C-terminal deletion mutant, Pip 1-410, can bind DNA independently (Figure 2A, compare lanes 2 and 3; Brass et al.,1996).”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
The deletion-analysis section reports that full-length Pip did not bind DNA independently in its gel-shift assay, while Pip 1–410 did. But the ‘Pip functions as a dichotomous regulator’ section says full-length Pip could bind DNA without PU.1 in cell extracts under different conditions, so the unqualified ‘cannot’ overstates the result. (LLM, conf=0.86)
Experimental — accuracy not yet measuredA predicted α-helix in Pip's C-terminus (aa 395-413) is critical for ternary complex formation and autoinhibition of DNA binding.
“we identified a predicted α-helix within Pip's C-terminus (amino acids 395-413) that is critical for both formation of a ternary complex and autoinhibition of DNA binding”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
The Structural basis section postulates that a putative α-helical region may play a key role in ternary complex formation and autoinhibition; the Model section identifies that region as amino acids 399–413, not 395–413. The paper’s deletion results establish the importance of a broader segment, amino acids 410–439, but do not establish that the predicted helix itself is critical. (LLM, conf=0.88)
Experimental — accuracy not yet measuredOther uncharacterized helices in Pip's region 150-340 may pack with helix 395-413 to form a fold competent for PU.1 association.
“it appears that other, as yet uncharacterized helices within this region may pack together with Pip's helix amino acids 395-413 to form a tertiary fold which is competent for PU.1 association.”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
In the deletion-analysis passage (page not available), removing Pip residues 150–340 weakened ternary complex formation with PU.1; the authors suggest that region may position the carboxy-terminal domain or contain another required region. In “Structural basis for PU.1-dependent DNA-binding of Pip” (page not available), they propose a role for a putative helix near residues 399–413. Our copy does not say that uncharacterized helices in residues 150–340 pack with it to form a tertiary fold. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Pip's regulatory domain autoinhibits Pip DNA binding in the absence of PU.1.
“In addition, this regulatory domain autoinhibits binding of Pip to DNA in the absence of PU.1.”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
Pip's regulatory domain contains structural determinants for both PU.1 interaction and autoinhibition.
“Therefore, this domain contains structural determinants important for both PU.1 interaction and autoinhibition (Brass et al., 1996).”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
A putative alpha-helical region in Pip's C-terminus (amino acids 399-413) was previously suggested to be important for ternary complex formation with PU.1.
“Previously, using deletion analysis and secondary structure predictions, we suggested that a putative α-helical region (amino acids 399-413) in Pip's C-terminus is important for ternary complex formation with PU.1 (Figure 1A and B; Brass et al., 1996).”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
PU.1 and Pip are major components of the ternary complex formed with nuclear extract from J558L cells.
“PU.1 and Pip represent the major components of the ternary complex formed with nuclear extract from these cells”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
This is consistent with increased Pip expression in plasma cell lines such as J558L.
“This is consistent with increased expression of Pip in plasma cell lines such as J558L”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
Probes B1 and C1 differ in their flanking sequences.
“Probes B1 and C1 differ in their flanking sequences”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Brass et al., 1996
The Gel mobility shift assays section describes a murine κB-site probe, and the Pip is NF-EM5 section describes complexes formed on that probe, but neither identifies probes B1 and C1 or compares their flanking sequences. Searches for “B1 and C1,” “C1 probe,” and “flanking sequences” found no passage addressing the claimed difference. (LLM, conf=0.75)
Experimental — accuracy not yet measuredPip/NF-EM5/IRF-4 is a lymphoid-restricted transcription factor recruited to a composite element (IRF/ETS-binding site) within Ig light chain enhancers through a specific interaction with PU.1 protein.
“Pip/NF-EM5/IRF-4, a member of IRF family, is a lymphoid-restricted transcription factor that is recruited to a composite element (IRF/ETS-binding site) within Ig light chain enhancers through a specific interaction with PU.1 protein [116, 117].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [117]
In the second step, phosphorylation of PU.1 at Ser 148 results in a conformational change in Pip (either before or after interaction with Pip) allowing cooperative DNA binding.
“In the second step, phosphorylation of PU.1 at Ser 148 results in a conformational change in Pip (either before or after interaction with Pip) allowing cooperative DNA binding [117].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [117]
The PU.1-ICSBP interaction is DNA directed and facilitated by EICE.
“Analogous to the PU.1-Pip interaction, the PU.1-ICSBP interaction is DNA directed and facilitated by EICE (4, 38).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [4]
ICSBP and Pip (IRF-4) are expressed only in the immune system.
“Although the majority of IRF family members are expressed broadly in many cell types, ICSBP and another member, Pip (IRF-4), are expressed only in the immune system (4, 12, 49).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [4]
The PU.1-ICSBP complex and the PU.1-Pip complex act as stimulators of EICE-mediated transcription.
“The PU.1ICSBP complex and the PU.1-Pip complex are shown to act as a stimulators of EICE-mediated transcription (4, 40).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [4]
ICSBP has been known to interact with PU.1, a hematopoietic-cell-specific member of the Ets family.
“ICSBP has been known to interact with PU.1, a hematopoietic-cellspecific member of the Ets family (4, 5, 38).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [4]
IRF-4 regulates an overlapping set of target promoters with ICSBP.
“IRF-4 is similar to ICSBP in structure, interacts with some common partners (PU.1 and E47), and regulates an overlapping set of target promoters. (31,32,63,64)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [64]
IRF-4 is similar to ICSBP in structure.
“IRF-4 is similar to ICSBP in structure, interacts with some common partners (PU.1 and E47), and regulates an overlapping set of target promoters. (31,32,63,64)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [64]
IRF-4 interacts with some partners common to ICSBP, namely PU.1 and E47.
“IRF-4 is similar to ICSBP in structure, interacts with some common partners (PU.1 and E47), and regulates an overlapping set of target promoters. (31,32,63,64)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,673 · see citing works
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,354 · see citing works
Garnier, J., Osguthorpe, D. J., & Robson, B. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90297-8 · Cited by 4,523 · see citing works
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808 · see citing works
Regulation of Inducible and Tissue-Specific Gene Expression
Maniatis, T., Goodbourn, S., & Fischer, J. A. (1987) · Science · doi:10.1126/science.3296191 · Cited by 1,553 · see citing works
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · see citing works
Self-citationHarada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957 · see citing works
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · see citing works
Field, J. M., Nikawa, J., Broek, D., MACDONALD, B. S., Rodgers, L., Wilson, I. A., Lerner, R. A., & Wigler, M. H. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.5.2159 · Cited by 949 · see citing works
Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A., & Baldwin, A. S. (1992) · Genes & Development · doi:10.17615/1ytj-h979 · Cited by 718 · see citing works
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672 · see citing works
Transcription activation by the adenovirus E1a protein
Lillie, J. W., & Green, M. R. (1989) · Nature · doi:10.1038/338039a0 · Cited by 668 · see citing works
[72] Identification of regulatory elements of cloned genes with functional assays
Rosenthal, N. A. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(87)52075-4 · Cited by 474 · see citing works
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · see citing works
Self-citationParker, D., Ferreri, K., Nakajima, T., Lamorte, V. J., Evans, R., Koerber, S. C., Hoeger, C., & Montminy, M. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.2.694 · Cited by 408 · see citing works
Veals, S. A., Schindler, C., Leonard, D. G. B., Fu, X.-Y., Aebersold, R. H., Darnell, J. E., Jr., & Levy, D. E. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3315 · Cited by 389 · see citing works
Harada, H., Willison, K. R., Sakakibara, J., Miyamoto, M., Fujita, T., & Taniguchi, T. (1990) · Cell · doi:10.1016/0092-8674(90)90163-9 · Cited by 368 · see citing works
Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1
Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E. L., & Taniguchi, T. (1989) · Nature · doi:10.1038/337270a0 · Cited by 358 · see citing works
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356 · see citing works
Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354 · see citing works
Immunoglobulin Gene Transcription
Staudt, L. M., & Lenardo, M. J. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002105 · Cited by 295 · see citing works
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 282 · see citing works
Bender, A., & Sprague, G. F. (1987) · Cell · doi:10.1016/0092-8674(87)90326-6 · Cited by 235 · see citing works
Kristie, T. M., LeBowitz, J. H., & Sharp, P. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08608.x · Cited by 233 · see citing works
Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 232 · see citing works
Gashler, A., Swaminathan, S., & Sukhatme, V. P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4556 · Cited by 227 · see citing works
Serwe, M., & Sablitzky, F. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05886.x · Cited by 217 · see citing works
Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196 · see citing works
Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588 · Cited by 192 · see citing works
Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588-599.1993 · Cited by 192 · see citing works
Olson, M. C., Scott, E. W., Hack, A. A., Su, G. H., Tenen, D. G., Singh, H., & Simon, M. C. (1995) · Immunity · doi:10.1016/1074-7613(95)90060-8 · Cited by 191 · see citing works
Self-citationEisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452 · Cited by 182 · see citing works
Self-citationModulation of Transcription Factor Ets-1 DNA Binding: DNA-Induced Unfolding of an α Helix
Petersen, J. M., Skalicky, J. J., Donaldson, L. W., McIntosh, L. P., Alber, T., & Graves, B. J. (1995) · Science · doi:10.1126/science.7569926 · Cited by 176 · see citing works
Xu, Y., Davidson, L., Alt, F. W., & Baltimore, D. (1996) · Immunity · doi:10.1016/s1074-7613(00)80251-4 · Cited by 169 · see citing works
Bovolenta, C., Driggers, P. H., Marks, M. S., Medin, J. A., Politis, A. D., Vogel, S. N., Levy, D. E., Sakaguchi, K., Appella, E., & Coligan, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5046 · Cited by 167 · see citing works
Galson, D. L., Hensold, J. O., Bishop, T. R., Schalling, M., D'Andrea, A. D., Jones, C., Auron, P. E., & Housman, D. E. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2929 · Cited by 147 · see citing works
Characterization of the Cooperative Function of Inhibitory Sequences in Ets-1
Jonsen, M. D., Petersen, J. M., Xu, Q.-P., & Graves, B. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2065 · Cited by 146 · see citing works
Veals, S. A., Maria, T. S., & Levy, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.196-206.1993 · Cited by 136 · see citing works
Shin, M. K., & Koshland, M. E. (1993) · Genes & Development · doi:10.1101/gad.7.10.2006 · Cited by 126 · see citing works
Regulation of the interferon system and cell growth by the IRF transcription factors
Taniguchi, T., Harada, H., & Lamphier, M. S. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01197763 · Cited by 115 · see citing works
Katan, M., Haigh, A., Verrijzer, C. P., van der Vliet, P. C., & O’Hare, P. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.23.6871 · Cited by 113 · see citing works
Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R., & Levi, B.-Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13063 · Cited by 100 · see citing works
Roberts, S. G. E., & Green, M. R. (1995) · Nature · doi:10.1038/375105a0 · Cited by 57 · see citing works
Hiramatsu, R., Akagi, K., Matsuoka, M., Sakumi, K., Nakamura, H., Kingsbury, L., David, C. S., Hardy, R. R., Yamamura, K., & Sakano, H. (1995) · Cell · doi:10.1016/0092-8674(95)90138-8 · Cited by 57 · see citing works
Möller, G. (1981) · Immunology Today · doi:10.1016/0167-5699(81)90060-8 · Cited by 57 · see citing works
McKnight, S. L. (1996) · Genes & Development · doi:10.1101/gad.10.4.367 · Cited by 46 · see citing works
Judde, J., & Max, E. E. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5206-5216.1992 · Cited by 45 · see citing works
Bluyssen, H. A., Vlietstra, R., van der Made, A. V. D., & Trapman, J. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18636.x · Cited by 42 · see citing works
Thornton, A. M., Buller, R. M. L., DeVico, A. L., Wang, I. M., & Ozato, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.383 · Cited by 34 · see citing works
Friedman, R. M., Merigan, T. C., Sreevalsan, T., & Factors, A. (1986) · Liss eBooks · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- McKnight, S. and Y. Yamamoto. 1992. Transcriptional regula- tion. Cold Spring Harbor Laboratory Press, Cold Spring Har- bor, NY.
Cited by
Sorted by citations
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658 · see citing works
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086 · see citing works
Lin, R., Heylbroeck, C., Pitha, P. M., & Hiscott, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2986 · Cited by 915 · see citing works
The development of inflammatory TH-17 cells requires interferon-regulatory factor 4
Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E., Mak, T. W., Kamradt, T., & Lohoff, M. D. (2007) · Nature Immunology · doi:10.1038/ni1500 · Cited by 691 · see citing works
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 570 · see citing works
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G. W., Xiao, W., Powell, J. I., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 524 · see citing works
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.014 · Cited by 554 · see citing works
Transcriptional Control of Dendritic Cell Development
Murphy, T. L., Grajales‐Reyes, G. E., Wu, X., Tussiwand, R., Briseño, C. G., Iwata, A., Kretzer, N. M., Durai, V., & MURPHY, K. M. M. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120204 · Cited by 484 · see citing works
The growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480 · see citing works
Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alunni, C., Natali–Tanci, L., Ugolini, B., et al. (2000) · Blood · doi:10.1182/blood.v95.6.2084 · Cited by 471 · see citing works
BATF–JUN is critical for IRF4-mediated transcription in T cells
Li, P., Spolski, R. J., Liao, W., Wang, L., Murphy, T. L., MURPHY, K. M. M., & Leonard, W. J. (2012) · Nature · doi:10.1038/nature11530 · Cited by 453 · see citing works
Re(de)fining the dendritic cell lineage
Satpathy, A. T., Wu, X., Albring, J. C., & MURPHY, K. M. M. (2012) · Nature Immunology · doi:10.1038/ni.2467 · Cited by 438 · see citing works
Pathogenesis of Human B Cell Lymphomas
Shaffer, A. L., Young, R. M., & Staudt, L. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075027 · Cited by 437 · see citing works
Tamura, T., Tailor, P. B., Yamaoka, K., Kong, H. J., Tsujimura, H., O’Shea, J. J., Singh, H., & Ozato, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2573 · Cited by 422 · see citing works
Self-citationSpecificity through cooperation: BATF–IRF interactions control immune-regulatory networks
Murphy, T. L., Tussiwand, R., & MURPHY, K. M. M. (2013) · Nature reviews. Immunology · doi:10.1038/nri3470 · Cited by 399 · see citing works
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
Bruchard, M., Rébé, C., Dérangère, V., Togbe, D., Ryffel, B., Boidot, R., Humblin, É., Hamman, A., Chalmin, F., Berger, H., et al. (2015) · Nature Immunology · doi:10.1038/ni.3202 · Cited by 394 · see citing works
Glasmacher, E., Agrawal, S., Chang, A. B., Murphy, T. L., Zeng, W., Vander Lugt, B., Khan, A. A., Ciofani, M., Spooner, C. J., Rutz, S., et al. (2012) · Science · doi:10.1126/science.1228309 · Cited by 361 · see citing works
Self-citationSpecificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344 · see citing works
DEVELOPMENT OF HUMAN LYMPHOID CELLS
Blom, B., & Spits, H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090612 · Cited by 338 · see citing works
Rengarajan, J., Mowen, K. A., McBride, K. D., Smith, E. D., Singh, H., & Glimcher, L. H. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011128 · Cited by 332 · see citing works
Self-citationPU.1 Regulates Expression of the Interleukin-7 Receptor in Lymphoid Progenitors
DeKoter, R. P., Lee, H.-J., & Singh, H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00269-8 · Cited by 319 · see citing works
Self-citationLin, R., Mamane, Y., & Hiscott, J. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2465 · Cited by 321 · see citing works
The ETS-domain transcription factor family
Sharrocks, A. D., Brown, A. L., Ling, Y., & Yates, P. R. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00086-1 · Cited by 317 · see citing works
Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311 · see citing works
Plasma cells: finding new light at the end of B cell development
Calame, K. L. (2001) · Nature Immunology · doi:10.1038/ni1201-1103 · Cited by 308 · see citing works
DeKoter, R. P., Walsh, J. C., & Singh, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4456 · Cited by 296 · see citing works
Self-citationDendritic cells in cancer immunology
Murphy, T. L., & MURPHY, K. M. M. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00741-5 · Cited by 272 · see citing works
Juang, Y.-T., Lowther, W. J., Kellum, M. J., Au, W.-C., Lin, R., Hiscott, J. B., & Pitha, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9837 · Cited by 266 · see citing works
The IRF Family Transcription Factors at the Interface of Innate and Adaptive Immune ResponsesPreprint
Ikushima, H., Negishi, H., & Taniguchi, T. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020321 · Cited by 269 · see citing works
Barnes, B. J., Kellum, M. J., Field, A. E., & Pitha, P. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5721-5740.2002 · Cited by 251 · see citing works
Autoinhibitory Domains: Modular Effectors of Cellular Regulation
Pufall, M. A., & Graves, B. J. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.031502.133614 · Cited by 232 · see citing works
Scott, E. W., Fisher, R. C., Olson, M. C., Kehrli, E. W., Simon, M. C., & Singh, H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80287-3 · Cited by 270 · see citing works
Self-citationRegulation of Ets function by protein–protein interactions
Li, R., Pei, H., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204035 · Cited by 229 · see citing works
A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway
Praetorius, C., Grill, C., Stacey, S. N., Metcalf, A. M., Gorkin, D. U., Robinson, K. C., Van Otterloo, E., Kim, R. S. Q., Bergsteinsdottir, K., Ogmundsdottir, M. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.022 · Cited by 228 · see citing works
A library of gene expression signatures to illuminate normal and pathological lymphoid biology
Shaffer, A. L., Wright, G. W., Yang, L., Powell, J. I., Ngo, V. N., Lamy, L., Lam, L. T., Davis, R. E., & Staudt, L. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00373.x · Cited by 228 · see citing works
The genetic network controlling plasma cell differentiation
Nutt, S. L., Taubenheim, N., Hasbold, J., Corcoran, L. M., & Hodgkin, P. D. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.010 · Cited by 224 · see citing works
Fujii, Y., Shimizu, T., Kusumoto, M., Kyogoku, Y., Taniguchi, T., & Hakoshima, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5028 · Cited by 223 · see citing works
Roles of interferon-regulatory factors in T-helper-cell differentiation
Lohoff, M. D., & Mak, T. W. (2005) · Nature reviews. Immunology · doi:10.1038/nri1552 · Cited by 214 · see citing works
Burýšek, L., Yeow, W.-S., Lubyová, B., Kellum, M. J., Schafer, S. L., Huang, Y. Q., & Pitha, P. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7334-7342.1999 · Cited by 212 · see citing works
Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation
Qin, B. Y., Liu, C., Lam, S. S., Srinath, H., Delston, R. B., Correia, J. J., Derynck, R., & Lin, K. F. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb1002 · Cited by 214 · see citing works
Acetylation-Dependent Signal Transduction for Type I Interferon Receptor
Tang, X., Gao, J., Guan, Y. A., McLane, K. E., Yuan, Z., Ramratnam, B., & Chin, Y. E. (2007) · Cell · doi:10.1016/j.cell.2007.07.034 · Cited by 211 · see citing works
Brass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 207 · see citing works
Self-citationRel Induces Interferon Regulatory Factor 4 (IRF-4) Expression in Lymphocytes
Grumont, R. J., & Gerondakis, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1281 · Cited by 198 · see citing works
Toll-Like Receptor Signaling and Regulation of Cytokine Gene Expression in the Immune System
Ozato, K., Tsujimura, H., & Tamura, T. (2002) · BioTechniques · doi:10.2144/oct0208 · Cited by 189 · see citing works
IRF4: Immunity. Malignancy! Therapy?
Shaffer, A. L., Emre, N. C. T., Romesser, P. B., & Staudt, L. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1845 · Cited by 189 · see citing works
Lee, C. H., Melchers, M., Wang, H., Torrey, T. A., Slota, R., Qi, C., Kim, J. Y., Lugar, P., Kong, H. J., Farrington, L. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051450 · Cited by 186 · see citing works
Wang, I.-M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., & Ozato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.271 · Cited by 187 · see citing works
Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells
Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183 · see citing works
Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry
Natkunam, Y., Warnke, R. A., Montgomery, K. D., Falini, B., & van de Rijn, M. (2001) · Modern Pathology · doi:10.1038/modpathol.3880373 · Cited by 175 · see citing works
Eklund, E. A., Jalava, A., & Kakar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13957 · Cited by 176 · see citing works
Transcription Factors in Lymphocyte Development— T and B Cells Get Together
Glimcher, L. H., & Singh, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80955-1 · Cited by 161 · see citing works
Self-citationTranscriptional regulation of follicular T‐helper (Tfh) cells
Liu, X., Nurieva, R., & Dong, C. (2013) · Immunological Reviews · doi:10.1111/imr.12040 · Cited by 158 · see citing works
Crystal structure of PU. 1/IRF-4/DNA ternary complex
Escalante, C. R., Brass, A. L., Pongubala, J. M. R., Shatova, E., Shen, L., Singh, H., & Aggarwal, A. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00703-7 · Cited by 154 · see citing works
Self-citationPhosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition
Cowley, D. O., & Graves, B. J. (2000) · Genes & Development · doi:10.1101/gad.14.3.366 · Cited by 152 · see citing works
Gu, T.-L., Goetz, T. L., Graves, B. J., & Speck, N. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.91-103.2000 · Cited by 150 · see citing works
Interferon regulatory factor family of transcription factors and regulation of oncogenesis
Takaoka, A., Tamura, T., & Taniguchi, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00720.x · Cited by 150 · see citing works
Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147 · see citing works
Marié, I., Smith, E., Prakash, A., & Levy, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8803-8814.2000 · Cited by 161 · see citing works
IRF8 regulates B-cell lineage specification, commitment, and differentiation
Wang, H., Lee, C. H., Qi, C., Tailor, P. B., Feng, J., Abbasi, S., Atsumi, T., & Morse, H. C. (2008) · Blood · doi:10.1182/blood-2008-01-129049 · Cited by 140 · see citing works
The diverse roles of IRF4 in late germinal center B‐cell differentiation
Silva, N. S. D., Simonetti, G., Heise, N., & Klein, U. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01113.x · Cited by 141 · see citing works
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 144 · see citing works
When Ets transcription factors meet their partners
Verger, A., & Duterque‐Coquillaud, M. (2002) · BioEssays · doi:10.1002/bies.10068 · Cited by 134 · see citing works
Monocyte differentiation and macrophage polarization
Orekhov, A. N., Orekhova, V. A., Nikiforov, N. G., Myasoedova, V. A., Grechko, A. V., Romanenko, E. B., Zhang, D., & Chistiakov, D. A. (2019) · Vessel Plus · doi:10.20517/2574-1209.2019.04 · Cited by 137 · see citing works
IRF5:RelA Interaction Targets Inflammatory Genes in Macrophages
Saliba, D. G., Heger, A., Eames, H. L., Oikonomopoulos, S., Teixeira, A. S., Blazek, K. D., Androulidaki, A., Wong, D., Goh, F. G., Weiss, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.034 · Cited by 133 · see citing works
Auto-Inhibition of Ets-1 Is Counteracted by DNA Binding Cooperativity with Core-Binding Factor α2
Goetz, T. L., Gu, T.-L., Speck, N. A., & Graves, B. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.81-90.2000 · Cited by 128 · see citing works
Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species?
Reynolds, G., & Haniffa, M. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00330 · Cited by 130 · see citing works
Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages
Tamura, T., Thotakura, P., Tanaka, T. S., Ko, M. S. H., & Ozato, K. (2005) · Blood · doi:10.1182/blood-2005-01-0080 · Cited by 133 · see citing works
Lineage-Specific Modulation of Interleukin 4 Signaling by Interferon Regulatory Factor 4
Gupta, S. K., Jiang, M., Anthony, A., & Pernis, A. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1837 · Cited by 128 · see citing works
Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brüstle, A., Weigmann, B., Atreya, R. N., Wirtz, S. J., Becker, C., Hoffman, A. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33227 · Cited by 130 · see citing works
Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU. 1 complex
Kanno, Y., Levi, B.-Z., Tamura, T., & Ozato, K. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.770 · Cited by 128 · see citing works
Masumi, A., Wang, I.-M., Lefebvre, B., Yang, X.-J., Nakatani, Y., & Ozato, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1810 · Cited by 124 · see citing works
IRF8 regulates myeloid and B lymphoid lineage diversification
Wang, H., & Morse, H. C. (2008) · Immunologic Research · doi:10.1007/s12026-008-8055-8 · Cited by 121 · see citing works
Luchin, A. I., Suchting, S., Merson, T. D., Rosol, T. J., Hume, D. A., Cassady, A. I., & Ostrowski, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106418200 · Cited by 123 · see citing works
Complex interactions of transcription factors in mediating cytokine biology in T cells
Li, P., Spolski, R. J., Liao, W., & Leonard, W. J. (2014) · Immunological Reviews · doi:10.1111/imr.12199 · Cited by 119 · see citing works
Ma, S., Pathak, S., Trinh, L. X., & Lu, R. (2007) · Blood · doi:10.1182/blood-2007-08-110106 · Cited by 117 · see citing works
Modulation of T Cell Cytokine Production by Interferon Regulatory Factor-4
Hu, C.-M., Jang, S. Y., Fanzo, J., & Pernis, A. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205895200 · Cited by 112 · see citing works
Marecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111 · see citing works
Interferon regulatory factor 4 and 8 in B-cell development
Lu, R. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.006 · Cited by 111 · see citing works
Nathanson, J. L. (2009) · Frontiers in Neural Circuits · doi:10.3389/neuro.04.019.2009 · Cited by 111 · see citing works
Oikawa, T., Yamada, T., Kihara-Negishi, F., Yamamoto, H., Kondoh, N., Hitomi, Y., & Hashimoto, Y. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400534 · Cited by 109 · see citing works
Transcriptional Control of Dendritic Cell Development
MURPHY, K. M. M. (2013) · Advances in immunology · doi:10.1016/b978-0-12-417028-5.00009-0 · Cited by 104 · see citing works
Roles of IFN Consensus Sequence Binding Protein and PU.1 in Regulating IL-18 Gene Expression
Kim, Y.-M., Kang, H.-S., Paik, S., Pyun, K.-H., Anderson, K. L., Torbett, B. E., & Choi, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2000 · Cited by 104 · see citing works
Zhao, B., & Sample, C. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5151-5160.2000 · Cited by 104 · see citing works
Raczkowski, F., Ritter, J., Heesch, K., Schumacher, V., Guralnik, A., Höcker, L., Raifer, H., Klein, M., Bopp, T., Harb, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309378110 · Cited by 98 · see citing works
Posttranslational Regulation of IRF-4 Activity by the Immunophilin FKBP52
Mamane, Y., Sharma, S., Petropoulos, L., Lin, R., & Hiscott, J. B. (2000) · Immunity · doi:10.1016/s1074-7613(00)80166-1 · Cited by 95 · see citing works
IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development
Ma, S., Turetsky, A., Trinh, L. X., & Lu, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7898 · Cited by 95 · see citing works
Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy
Jiang, D., Bian, Z., Zhang, Y., Zhang, S.-M., Liu, Y., Zhang, R., Chen, Y., Yang, Q., Zhang, X.-D., Fan, G., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00614 · Cited by 92 · see citing works
NF-IL6 (C/EBPβ) Vigorously Activates il1b Gene Expression via a Spi-1 (PU.1) Protein-Protein Tether
Yang, Z., Wara-aswapati, N., Chen, C., Tsukada, J., & Auron, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000145200 · Cited by 92 · see citing works
Guria, S., Hoory, A., Das, S., Chattopadhyay, D., & Mukherjee, S. (2023) · Bioscience Reports · doi:10.1042/bsr20220200 · Cited by 98 · see citing works
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87 · see citing works
Himmelmann, A. W., Riva, A., Wilson, G. L., Lucas, B. P., Thévenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 84 · see citing works
Wang, H., Jain, S., Li, P., Lin, J.-X., Oh, J., Qi, C., Gao, Y., Sun, J., Sakai, T., Naghashfar, Z., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901258116 · Cited by 81 · see citing works
IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
Biswas, P. S., Bhagat, G., & Pernis, A. B. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00864.x · Cited by 81 · see citing works
Little, H., Rorick, N. K., Su, L.-I., Baldock, C., Malhotra, S., Jowitt, T., Gakhar, L., Ramaswamy, S., Schutte, B. C., Dixon, M. J., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn381 · Cited by 80 · see citing works
Gupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74 · see citing works
Gualco, G., Weiss, L. M., & Bacchi, C. E. (2010) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3181cf1126 · Cited by 78 · see citing works
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77 · see citing works
PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74 · see citing works
IRF4 in multiple myeloma—Biology, disease and therapeutic target
Agnarelli, A., Chevassut, T. J. T., & Mancini, E. J. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.07.025 · Cited by 76 · see citing works
Transcriptional regulation of B-cell differentiation
Reya, T., & Grosschedl, R. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80244-6 · Cited by 76 · see citing works
- Authors
- Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Singh, H
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1996-09-15
- Volume
- 10
- Issue
- 18
- Pages
- 2335-2347
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2005606581
- Cited by
- 242
- References
- 49
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 6 · 2014: 7 · 2013: 15 · 2012: 11
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- York University
- National Institutes of Health
- U.S. Public Health Service (FM07183)
- National Institute of General Medical Sciences (T32GM007281, GM-07281)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-07009)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- Pip, interferon regulatory factors, PU.1, ETS transcription factors, ternary complex formation, autoinhibition, B cell activation, transcriptional repression, p48, DNA-binding domain
- MeSH terms
- Interferon Regulatory Factor-8, Interferon Regulatory Factor-4, Proto-Oncogene Protein Spi-1, Animals, B-Lymphocytes, Binding Sites, Carrier Proteins, DNA-Binding Proteins, Gene Expression Regulation, Interferon-gamma, Models, Molecular, Nucleic Acid Conformation, Protein Conformation, Proto-Oncogene Proteins, Regulatory Sequences, Nucleic Acid, Repressor Proteins, Transcription Factors, Transcription, Genetic, Trans-Activators, Interferon-alpha, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review